Emend - supply shortage
Resolved
aprepitant
Shortage
Human
Shortage information
The shortage affecting Emend has been resolved and the information and recommendations which were issued during the shortage no longer apply.
Key facts
- Medicines affected
- Emend
- Supply shortage status
- Resolved
- International non-proprietary name (INN) or common name
- aprepitant
- Therapeutic area (MESH)
- Vomiting
- Postoperative Nausea and Vomiting
- Cancer
- Neoplasms
- Pharmaceutical forms affected
- Powder for oral suspension
- Strengths affected
- 80 mg
- 125 mg
Key dates
- First published
- Last updated